WAVE Life Sciences(WVE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

WVE WAVE Life Sciences

Market Closed 12-12 16:00:00 EST

16.56

-0.19

-1.13%

盘后16.68

+0.12+0.72%

19:58 EST

High17.77	Low15.86	Vol8.10M
Open17.38	D1 Closing16.75	Amplitude11.40%
Mkt Cap2.77B	Tradable Cap1.60B	Total Shares167.00M
T/O133.90M	T/O Rate8.37%	Tradable Shares96.81M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"WVE","market":"US","secType":"STK","nameCN":"WAVE Life Sciences","latestPrice":16.56,"timestamp":1765573200000,"preClose":16.75,"halted":0,"volume":8100050,"hourTrading":{"tag":"盘后","latestPrice":16.68,"preClose":16.56,"latestTime":"19:58 EST","volume":34968,"amount":580201.3528,"timestamp":1765587493902},"delay":0,"floatShares":96808300,"shares":167000000,"eps":-0.743552,"marketStatus":"Market Closed","change":-0.19,"latestTime":"12-12 16:00:00 EST","open":17.38,"high":17.77,"low":15.86,"amount":133895446.51,"amplitude":0.11403,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.743552,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1447218000000,"exchange":"NASDAQ","adjPreClose":16.75,"preHourTrading":{"tag":"盘前","latestPrice":17.4782,"preClose":16.75,"latestTime":"09:29 EST","volume":98978,"amount":1717988.1669939999,"timestamp":1765549774524},"postHourTrading":{"tag":"盘后","latestPrice":16.68,"preClose":16.56,"latestTime":"19:58 EST","volume":34968,"amount":580201.3528,"timestamp":1765587493902},"volumeRatio":0.18330103795823413,"impliedVol":0.8989,"impliedVolPercentile":0.432},"requestUrl":"/m/hq/s/WVE/wiki","defaultTab":"wiki","newsList":[{"id":"2590507751","title":"Wave Life Sciences' Robust 2026 Pipeline to Support Outlook, Wedbush Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2590507751","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590507751?lang=en_us&edition=fundamental","pubTime":"2025-12-12 23:25","pubTimestamp":1765553109,"startTime":"0","endTime":"0","summary":"Wave Life Sciences'  PRISM technology platform is expected to support a robust pipeline for 2026 and its outlook, Wedbush said in a note Friday, adding the stock to its \"Best Ideas List.\"The upcoming WVE-007 higher-dose readouts in Q1 and Q2 2026, a WVE-006 update in alpha-1 antitrypsin deficiency in Q1 2026, and an expected New Drug Application submission for WVE-N531 in Duchenne muscular dystrophy, are expected to support the company's numbers going forward, the investment firm said.Wedbush said it raised its probability-of-success estimate for WVE-007 to 50% from 25% and models it as a potential monotherapy in obesity in addition to an add-on approach with GLP-1 therapies.Wedbush's 2035 worldwide revenue view for WVE-007 is $8.3 billion across monotherapy and add-on use, up from a prior $2.5 billion estimate focused on add-on use alone, according to the note.WVE-006 is also part of the company's broader validation case for Wave's RNA editing approach, including a possible 2026 clini","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","WVE"],"gpt_icon":1},{"id":"2590509815","title":"Wave Life Sciences Is Maintained at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2590509815","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590509815?lang=en_us&edition=fundamental","pubTime":"2025-12-12 20:50","pubTimestamp":1765543800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/WVE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 12, 2025 07:50 ET (12:50 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","WVE"],"gpt_icon":0},{"id":"2590407506","title":"Wave Life Sciences Ltd : Wedbush Raises Target Price to $33 From $20","url":"https://stock-news.laohu8.com/highlight/detail?id=2590407506","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590407506?lang=en_us&edition=fundamental","pubTime":"2025-12-12 20:46","pubTimestamp":1765543567,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"d86fc1a050ef35f0b0e63806145f697e","theme_name":"🔥TrendingNo.30 · Wave Life Sciences Stock Price Target Raised by Wedbush and B. Riley Securities, Ratings Maintained","theme_type":2,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nFWN3XI137:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","WVE"],"gpt_icon":0},{"id":"2590503038","title":"Wedbush Raises Price Target on Wave Life Sciences to $33 From $20, Adds to Best Ideas List, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2590503038","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590503038?lang=en_us&edition=fundamental","pubTime":"2025-12-12 19:49","pubTimestamp":1765540161,"startTime":"0","endTime":"0","summary":"Wave Life Sciences (WVE) has an average rating of buy and mean price target of $29.88, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["WVE","BK4007"],"gpt_icon":0},{"id":"2590563578","title":"Wave Life Sciences Director Mark Corrigan Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590563578","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590563578?lang=en_us&edition=fundamental","pubTime":"2025-12-11 10:45","pubTimestamp":1765421146,"startTime":"0","endTime":"0","summary":"Mark Corrigan, Director at Wave Life Sciences Ltd., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wave Life Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 10, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"b038ff687efe36210ac6c40aceddb1eb","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL3xg6Ln:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Wave Life Sciences Director Mark Corrigan Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","WVE"],"gpt_icon":1},{"id":"2590095533","title":"Wave Life Sciences Shares Drop After Equity Offering Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2590095533","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590095533?lang=en_us&edition=fundamental","pubTime":"2025-12-10 22:52","pubTimestamp":1765378320,"startTime":"0","endTime":"0","summary":"Wave Life Sciences' shares fell sharply after the clinical-stage biotechnology company priced an upsized $350 million equity raising.The shares were down 10% at $19.09 in early trading Wednesday, narrowing the advance in 2025 to 54%.Wave Life late Tuesday said an underwritten public offering of 15.8 million of its shares was priced at $19 apiece, along with warrants to buy 2.63 million shares at $18.9999 each.The company granted the underwriters a 30-day option to buy up to an additional 2.76 million of its shares on the same terms.Wave Life on Monday launched an offering of $250 million of its shares and warrants.The offering is expected to close on or about Thursday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4215","WVE","EQR","BK4588","BK4007"],"gpt_icon":1},{"id":"2590374381","title":"BRIEF-Wave Life Sciences Prices Upsized $350 Million Offering At A Price of $19 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2590374381","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590374381?lang=en_us&edition=fundamental","pubTime":"2025-12-10 10:52","pubTimestamp":1765335122,"startTime":"0","endTime":"0","summary":"BRIEF-Wave Life Sciences Prices Upsized $350 Million Offering At A Price of $19 Per ShareDec 9 (Reuters) - WAVE Life Sciences Ltd WVE.O:WAVE LIFE SCIENCES PRICES UPSIZED $350 MILLION PUBLIC OFFERING O","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XF0J5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","WVE"],"gpt_icon":1},{"id":"2590374809","title":"Wave Life Sciences Ltd -  Prices Public Offering of 15.8 Mln  Shares at a Price of $19.00 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2590374809","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590374809?lang=en_us&edition=fundamental","pubTime":"2025-12-10 10:50","pubTimestamp":1765335008,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XF0J5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WVE","BK4007"],"gpt_icon":0},{"id":"2590291443","title":"Wave Life Sciences Adds to Gains After Analysts Raise Price Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=2590291443","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590291443?lang=en_us&edition=fundamental","pubTime":"2025-12-10 04:15","pubTimestamp":1765311300,"startTime":"0","endTime":"0","summary":"Wave Life Sciences shares, which skyrocketed Monday on favorable interim Phase 1 data for weight loss drug WVE-007, gained on Tuesday after analysts raised price targets.Shares rose 147% to $18.52 on Monday, and were recently up 14% to $21.18. They touched a 52-week high of $21.73.Wells Fargo raised its price target to $29 from $16, while RBC Capital raised its target to $27 from $9. Citigroup, Canaccord Genuity, Clear Street and Cantor Fitzgerald also increased their price targets.Wave Life Sciences said that following a single subcutaneous 240-mg dose, WVE-007 improved body composition at three months compared to baseline, with a 9.4% reduction in visceral fat.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","WVE"],"gpt_icon":1},{"id":"2590329183","title":"Wave Life Sciences Shares Rise After RBC Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2590329183","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590329183?lang=en_us&edition=fundamental","pubTime":"2025-12-10 04:09","pubTimestamp":1765310959,"startTime":"0","endTime":"0","summary":"Wave Life Sciences  shares rose more than 14% in recent Tuesday trading after RBC Capital Markets upgraded the stock to outperform from sector perform and raised its price target to $27 from $9.Trading volume stood at over 23.7 million compared with a daily average of about 4.9 million.Price: 21.16, Change: +2.64, Percent Change: +14.25","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"830c8330d409845e04ca5a0e66727d79","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["WVE","BK4007"],"gpt_icon":0},{"id":"2590217326","title":"What's Going On With Wave Life Sciences Stock Tuesday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2590217326","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590217326?lang=en_us&edition=fundamental","pubTime":"2025-12-10 03:11","pubTimestamp":1765307460,"startTime":"0","endTime":"0","summary":"Wave Life Sciences rises after new WVE-007 weight-loss data and multiple analyst upgrades, alongside a $250 million offering announcement.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/09/Why-Diet-Soda-Might-Harm.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/09/Why-Diet-Soda-Might-Harm.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/25/12/49289117/whats-going-on-with-wave-life-sciences-stock-tuesday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/12/49289117/whats-going-on-with-wave-life-sciences-stock-tuesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["WVE","BK4007"],"gpt_icon":1},{"id":"1148703051","title":"Stock Track | WAVE Life Sciences Soars 13.39% Intraday on Positive Obesity Drug Data and Analyst Upgrades","url":"https://stock-news.laohu8.com/highlight/detail?id=1148703051","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148703051?lang=en_us&edition=fundamental","pubTime":"2025-12-10 02:46","pubTimestamp":1765305984,"startTime":"0","endTime":"0","summary":"WAVE Life Sciences (WVE) surged 13.39% intraday on Tuesday, continuing its upward momentum following promising interim Phase 1 trial results for its investigational obesity therapy, WVE-007.The data...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"555c7582c603e30adb6ccf2ae0112896","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["WVE"],"gpt_icon":1},{"id":"2590334503","title":"Wave Life Sciences Is Maintained at Buy by Clear Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2590334503","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590334503?lang=en_us&edition=fundamental","pubTime":"2025-12-09 20:30","pubTimestamp":1765283400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/WVE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 09, 2025 07:30 ET (12:30 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"cb02a08a52cd2848e5afda66025e6225","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","WVE"],"gpt_icon":0},{"id":"1194446149","title":"Stock Track | WAVE Life Sciences Soars 5.18% in Pre-Market on Positive Obesity Drug Trial Results and Analyst Upgrades","url":"https://stock-news.laohu8.com/highlight/detail?id=1194446149","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194446149?lang=en_us&edition=fundamental","pubTime":"2025-12-09 19:48","pubTimestamp":1765280908,"startTime":"0","endTime":"0","summary":"WAVE Life Sciences (WVE) surged 5.18% in pre-market trading following the release of promising interim Phase 1 trial data for its investigational obesity therapy, WVE-007. The results showed a 9.4%...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"0d850c2dc13857825ff7bfc8889a623d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["WVE"],"gpt_icon":1},{"id":"2590348513","title":"RBC Upgrades Wave Life Sciences to Outperform From Sector Perform, Boosts Price Target to $27 From $9, Keeps Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2590348513","media":"MT Newswires Live","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590348513?lang=en_us&edition=fundamental","pubTime":"2025-12-09 19:28","pubTimestamp":1765279683,"startTime":"0","endTime":"0","summary":"Wave Life Sciences (WVE) has an average rating of buy and mean price target of $28.75, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"cb02a08a52cd2848e5afda66025e6225","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","WVE"],"gpt_icon":0},{"id":"2590310019","title":"Wave Life Sciences Ltd : Citigroup Raises Target Price to $30 From $16","url":"https://stock-news.laohu8.com/highlight/detail?id=2590310019","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590310019?lang=en_us&edition=fundamental","pubTime":"2025-12-09 19:18","pubTimestamp":1765279126,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"cb02a08a52cd2848e5afda66025e6225","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nFWN3XF06R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","WVE"],"gpt_icon":0},{"id":"1195100840","title":"Premarket Movers | Ares Management Jumps over 8% on S&P 500 Inclusion; Wave Life Sciences Rises Another 4%; WBD Pops Nearly 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1195100840","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195100840?lang=en_us&edition=fundamental","pubTime":"2025-12-09 17:11","pubTimestamp":1765271514,"startTime":"0","endTime":"0","summary":"Shares of $Ares Management(ARES)$  jumped over 8% in premarket trading. Ares Management will join the S&P 500 before market open on December 11, S&P Dow Jones Indices said on Monday, becoming the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"553b3113a8a6433b16057fe4e53db338","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARES","WBD","SEZL","VITL","WVE"],"gpt_icon":0},{"id":"2590360258","title":"Nvidia, AMD, Wave Life Sciences, Toll Brothers And Carvana: Why These 5 Stocks Are On Investors' Radars Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2590360258","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590360258?lang=en_us&edition=fundamental","pubTime":"2025-12-09 09:17","pubTimestamp":1765243020,"startTime":"0","endTime":"0","summary":"NVDA, AMD, WVE, TOL, CVNA were among the stocks seen trending on Monday, Dec. 8, 2025.","market":"nz","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/08/Creative-Glowing-Candlestick-Forex-Chart.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/08/Creative-Glowing-Candlestick-Forex-Chart.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/25/12/49272368/nvidia-amd-wave-life-sciences-toll-brothers-and-carvana-why-these-5-stocks-are-on-investors-radars-today","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/25/12/49272368/nvidia-amd-wave-life-sciences-toll-brothers-and-carvana-why-these-5-stocks-are-on-investors-radars-today","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["LU2360107168.USD","LU1778281490.HKD","SG9999015952.SGD","LU0109391861.USD","LU0077335932.USD","LU0082616367.USD","LU1861127337.USD","LU1551013425.SGD","LU1935043023.USD","LU0494093205.USD","LU1791710400.SGD","LU2361044949.HKD","LU0069063385.USD","BK4550","IE0005OL40V9.USD","BK4551","BK4587","LU2168564222.USD","LU0354030438.USD","LU0985320562.USD","LU2322448791.USD","LU0203201768.USD","LU0061474705.USD","LU2125909593.SGD","IE00BMPRXR70.SGD","BK4512","LU0820561818.USD","BK4573","IE0004445239.USD","IE00B1BXHZ80.USD","LU0820561909.HKD","LU0029864427.USD","IE0004445015.USD","LU2756315318.SGD","LU1868836914.USD","LU1069344957.HKD","LU0158827948.USD","LU0672654240.SGD","LU1116320737.USD","LU1429558221.USD","LU0342679015.USD","LU2236285917.USD","IE00BMPRXQ63.HKD","LU2403377893.USD","LU2237438978.USD","LU1712237335.SGD","LU0889565833.HKD","LU1934455194.USD","LU1935042991.SGD","LU1145028129.USD","LU2083900584.USD","LU0234570918.USD","IE00BN29S564.USD","BK4567","LU0308772762.SGD","LU2089283258.USD","LU1815336760.USD","LU0128525929.USD","LU2272731782.SGD","SG9999014575.USD","LU2249611893.SGD","LU0274383776.USD","LU0823434583.USD","SG9999015358.SGD","LU2473716301.USD","LU0210528500.USD","NVDY","LU1861215975.USD","LU2290526834.HKD","LU2360032135.SGD","SG9999014898.SGD","BK4533","LU0965509283.SGD","LU2491050154.USD","LU0079474960.USD","SG9999018865.SGD","IE00B4JS1V06.HKD","LU0127658192.USD","LU1791710582.SGD","LU1923623000.USD","LU1821325948.USD","SG9999017495.SGD","LU0256863811.USD","BK4529","BK4585","LU2065170008.USD","LU0211327993.USD","NVIW.SI","LU0640476718.USD","NVDS.UK","LU0256863902.USD","LU0823414551.USD","LU1280957306.USD","IE00BMPRXN33.USD","LU2360106780.USD","LU1548497426.USD","LU2452424414.USD","LU0345769631.USD","LU2294711713.HKD","LU2420271590.USD","LU0472753341.HKD","BK4614","BK4579","LU0683600562.USD","LU0251132253.USD","SG9999002224.SGD","IE000KEQY171.SGD","LU1267930490.SGD","LU1992135472.HKD","LU2247934214.USD","HK0000320264.USD","LU1923622291.USD","LU0215105999.USD","IE000ITXATA3.USD","LU0109392836.USD","IE00BDCRKT87.USD","LU0868494617.USD","LU2250418816.HKD","LU0198837287.USD","LU0096362180.USD","LU0528227936.USD","LU0823421416.USD","IE00B4YYXB79.USD","BK4543","LU1852331112.SGD","LU2213496289.HKD","SG9999014567.USD","LU2125909916.SGD","SG9999001424.SGD","LU0708995401.HKD","LU2168564495.EUR","BK4532","LU0868494708.USD","LU2271345857.HKD","LU0061474960.USD","LU1066051225.USD","BK4548","LU2458330169.SGD","HK0000306701.USD","LU2357125470.USD","LU2125909247.SGD","IE00B5949003.HKD","LU0289960550.SGD","SG9999015978.USD","IE00BFSS7M15.SGD","SG9999014906.USD","IE000YTNTUN2.SGD","LU0266013472.USD","LU1323610961.USD","LU2063271972.USD","LU2461242641.AUD","LU2108987350.USD","BK4534","LU0689626769.HKD","IE00BK4W5L77.USD","LU1435385759.SGD","LU2505996681.GBP","SGXZ99366536.SGD","LU0175139822.USD","SGXZ51526630.SGD","LU0942090050.USD","LU0689472784.USD","LU2065171402.SGD","LU1037948541.HKD","LU2106854487.HKD","LU2168564149.EUR","LU2931357623.SGD","LU1803068979.SGD","LU2602419157.SGD","WVE","LU2054465674.USD","LU2237957902.USD","LU2023251221.USD","LU0965509010.AUD","BK4612","SGXZ31699556.SGD","IE00B3SWFQ91.USD","LU1623119135.USD","NVDD","LU2125154935.USD","LU0957791311.USD","LU0310800379.SGD","LU2326559502.SGD","LU2746668974.SGD","IE00BQXX3C00.GBP","IE00BQXX3D17.EUR","LU1989772923.USD","LU0345768153.USD","LU1989764664.SGD","LU1064131342.USD","LU1066051498.USD","LU2125909759.SGD","LU0276348264.USD","LU0170899867.USD","LU1992135399.USD","LU1551013342.USD","IE00BDRTCR15.USD","LU1804176565.USD","LU1951200564.SGD","IE00B19Z8W00.USD","LU0345770308.USD","LU1861559042.SGD","LU0053666078.USD","LU2433249047.HKD","LU2087625088.SGD","IE0004086264.USD","BK4549","LU0786609619.USD","LU1914381329.SGD","IE00BD6J9T35.USD","LU1988902786.USD","BK4141","BK4598","LU1880398554.USD","LU0056508442.USD","LU0466842654.USD","LU1868836591.USD","LU1066053197.SGD","IE00BHPRN162.USD","LU2417539215.USD","LU0708994859.HKD","LU0006306889.USD","LU2065171311.SGD","LU2462157665.USD","NVDX","LU1232071149.USD","LU0943347566.SGD","LU1983260115.SGD","LU1633808545.USD","LU2092627202.USD","LU2265009873.SGD","SG9999014542.SGD","LU0187121727.USD","SGXZ23171101.USD","IE0004091025.USD","LU0225283273.USD","CVNA","LU0557290698.USD","LU2463028550.USD","LU0823434740.USD","LU0267386448.USD","LU1267930730.SGD","BK4575","LU2491050071.SGD","LU2592432038.USD","LU0080751232.USD","SG9999004303.SGD","LU2272731865.HKD","LU0211328371.USD","IE0001KFT4U8.USD","LU1037948897.HKD","LU0347712357.USD","IE00BQXX3F31.USD","LU0511384066.AUD","LU0154236417.USD","SG9999018857.SGD","BK4566","LU2191332357.HKD","LU1366333091.USD","LU2168564065.EUR","LU2746668461.USD","LU1974910355.USD","LU1267930573.SGD","SG9999014559.SGD","LU0642271901.SGD","LU1366192091.USD","LU0061475181.USD","SG9999014914.USD","IE00BZ1G4Q59.USD","SNVD.UK","LU1868836757.USD","BK4592","LU2543165471.USD","LU2458330243.SGD","LU2471134523.USD","LU2750360997.AUD","HK0000320223.HKD","LU0124676726.USD","LU2430703178.SGD","GB00BDT5M118.USD","LU1303367103.USD","LU2098885051.SGD","LU1244550577.SGD","IE00BKPKM429.USD","LU1720051108.HKD","NVDA","LU1935042488.USD","LU2111349929.HKD","LU2077746001.SGD","LU0289739343.SGD","LU2087621335.USD","LU1868837300.USD","LU1951198990.SGD","LU1244550221.USD","SG9999015341.SGD","LU1242518857.USD","LU1496350171.SGD","LU2023250330.USD","SG9999015945.SGD","IE00BJJMRY28.SGD","NVD","LU0316494557.USD","LU0820562030.AUD","NVD2.UK","LU2065169927.USD","LU0210536198.USD","LU2896262040.SGD","SG9999002232.USD","NVDS","IE0034235188.USD","LU2506951792.HKD","LU1244550494.USD","LU2860962120.EUR","LU2244417387.USD","LU0238689110.USD","LU0788109477.HKD","LU1720051017.SGD","IE00B19Z8X17.USD","LU1116320901.HKD","LU2089284900.SGD","LU0964807845.USD","LU1917777945.USD","LU0354030511.USD","LU1642822529.SGD","LU0882574139.USD","LU0719512351.SGD","LU2322448957.HKD","LU1066051811.HKD","LU1316542783.SGD","LU2097344431.USD","LU0048584097.USD","LU0957808578.USD","IE00BZ199S13.USD","IE0003U64NQ7.SGD","IE0034235303.USD","LU0096364046.USD","LU0070217475.USD","LU2756315664.SGD","LU1815333072.USD","BK4088","IE00BYXW3230.USD","LU2552382132.HKD","SG9999000418.SGD","LU2264538146.SGD","IE00BJTD4V19.USD","LU1496350502.SGD","LU0476273544.USD","LU0823414478.USD","IE00B3M56506.USD","LU1868837136.USD","LU0234572021.USD","LU0444973449.USD","LU2242650005.HKD","LU2487616109.SGD","LU1718418525.SGD","LU1119994496.HKD","IE00BFSS8Q28.SGD","LU0965508806.USD","LU2471134879.HKD","LU2381873111.SGD","IE00BJLML261.HKD","LU2092937148.SGD","BK4608","LU1935043536.SGD","LU0353189680.USD","LU0345770993.USD","LU0320765059.SGD","LU0444971666.USD","LU2168563687.JPY","LU0106261372.USD","LU1861558580.USD","LU2286300806.USD","LU1035775433.USD","LU1674673428.USD","LU0158827781.USD","SG9999015986.USD","HK0000306685.HKD","IE00B1XK9C88.USD","LU1935042215.USD","BK4503","IE00BJJMRX11.SGD","LU1934455277.USD","IE0009356076.USD","TOL","LU1934455863.HKD","LU0097036916.USD","LU1629891620.HKD","LU0072462426.USD","BK4554","LU0210533765.USD","SG9999014880.SGD","LU2456880835.USD","LU2552382058.USD","LU0787776722.HKD","LU1839511570.USD","LU2357305700.SGD","LU1721428933.USD","IE000W1ABFV2.USD","LU0724617625.USD","LU2471134952.CNY","LU2552382215.SGD","BK4588","LU1989772840.SGD","IE00BKDWB100.SGD","LU2471134796.USD","AMD","IE0034235295.USD","IE00B775H168.HKD","LU0157215616.USD","LU2211815571.USD","LU2413666699.HKD","NVDU","LU2413666426.HKD","LU2430703095.HKD","LU0057025933.USD","LU1880398471.USD","IE00BWXC8680.SGD","LU0081259029.USD","LU2430703251.USD","LU1861220033.SGD","LU2028103732.USD","LU0289961442.SGD","LU2750360641.GBP","LU2089985449.USD","LU0965509101.SGD","LU2237957811.SGD","LU0417517546.SGD","NVD3.UK","BK4581","LU2505996509.AUD","LU1989764748.USD","LU0823421333.USD","IE00BK4W5M84.HKD","LU0353189763.USD","BK4527","LU1923622614.USD","LU0345769128.USD","2NVD.UK","LU1084165304.USD","IE00BJTD4N35.SGD","IE00B19Z9505.USD","IE00B7KXQ091.USD","LU2272731600.USD","LU1571399168.USD","LU2491049909.HKD","IE00BKVL7J92.USD","LU2023250504.SGD","LU0310799852.SGD","LU0265550946.USD","LU0345768740.USD","3NVD.UK","BK4211","LU0390134368.USD","LU0323591593.USD","LU1814569148.SGD","LU0979878070.USD","LU1674673691.USD","LU0094547139.USD","IE0009G5SDU7.USD","LU0203202063.USD","LU0107464264.USD","LU2097344357.USD","LU1127390331.HKD","LU1261432733.SGD","LU2361044865.SGD","LU0054578231.USD","BK4214","LU2361045086.USD","LU0861579265.USD","LU2355687059.USD","LU0265550359.USD","BK4605","LU1699723380.USD","LU0348723411.USD","SGXZ81514606.USD","LU1242518931.SGD","LU2242649171.HKD","LU2125154778.USD"],"gpt_icon":1},{"id":"1173510050","title":"Stock Track | WAVE Life Sciences Soars 5.56% on Positive Phase 1 Obesity Drug Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1173510050","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173510050?lang=en_us&edition=fundamental","pubTime":"2025-12-09 09:08","pubTimestamp":1765242535,"startTime":"0","endTime":"0","summary":"WAVE Life Sciences (WVE) saw its stock surge 5.56% intraday on Monday following the release of promising interim data from its Phase 1 trial for WVE-007, an investigational obesity treatment. The...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"cb02a08a52cd2848e5afda66025e6225","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["WVE"],"gpt_icon":1},{"id":"1121475701","title":"Form 144 | WAVE LIFE SCIENCES LTD.'s Officer Christopher Francis proposes to sell 483,602 Shares, with a total value of approximately $3.62 Million.","url":"https://stock-news.laohu8.com/highlight/detail?id=1121475701","media":"Filings Track","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121475701?lang=en_us&edition=fundamental","pubTime":"2025-12-09 05:40","pubTimestamp":1765230020,"startTime":"0","endTime":"0","summary":"WAVE LIFE SCIENCES LTD.'s Officer Christopher Francis plans to sell 483,602 common shares on December 8, 2025, with a total market value of approximately $3.62 million. Christopher Francis has made no sales in the past three months.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Form 144 | WAVE LIFE SCIENCES LTD.'s Officer Christopher Francis proposes to sell 483,602 Shares, with a total value of approximately $3.62 Million.","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WVE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wavelifesciences.com","stockEarnings":[{"period":"1week","weight":1.2109},{"period":"1month","weight":1.381},{"period":"3month","weight":1.3759},{"period":"6month","weight":1.3827},{"period":"1year","weight":0.1957},{"period":"ytd","weight":0.3387}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Wave Life Sciences Ltd., a clinical-stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid (RNA) to correct disease-causing mutations, modulate protein activity, restore the production of functional proteins, or reduce the expression of disease-promoting RNAs or proteins. The company also develops WVE-004, a C9orf72 molecule for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia; WVE-003, a mutant huntingtin SNP3 molecule for the treatment of Huntington's disease; WVE-N531, an Exon 53 molecule for the treatment of Duchenne muscular dystrophy; WVE-006, the SERPINA1 molecule for the treatment of Alpha-1 antitrypsin deficiency (AATD); and ATXN3, a discovery stage program for the treatment of spinocerebellar ataxia 3, as well as multiple preclinical programs for CNS disorders, including Alzheimer's and Parkinson's diseases. It has collaboration agreements with Pfizer Inc., Takeda Pharmaceutical Company Limited, and Glaxo Group Limited. The company was incorporated in 2012 and is based in Singapore.","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":-0.065604},{"month":2,"riseRate":0.7,"avgChangeRate":0.067262},{"month":3,"riseRate":0.3,"avgChangeRate":-0.085138},{"month":4,"riseRate":0.2,"avgChangeRate":-0.079373},{"month":5,"riseRate":0.5,"avgChangeRate":0.001154},{"month":6,"riseRate":0.5,"avgChangeRate":0.136995},{"month":7,"riseRate":0.5,"avgChangeRate":0.010097},{"month":8,"riseRate":0.8,"avgChangeRate":0.166322},{"month":9,"riseRate":0.4,"avgChangeRate":0.023822},{"month":10,"riseRate":0.5,"avgChangeRate":0.114526},{"month":11,"riseRate":0.6,"avgChangeRate":0.099642},{"month":12,"riseRate":0.181818,"avgChangeRate":0.002965}],"exchange":"NASDAQ","name":"WAVE Life Sciences","nameEN":"WAVE Life Sciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"WAVE Life Sciences(WVE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest WAVE Life Sciences(WVE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"WAVE Life Sciences,WVE,WAVE Life Sciences股票,WAVE Life Sciences股票老虎,WAVE Life Sciences股票老虎国际,WAVE Life Sciences行情,WAVE Life Sciences股票行情,WAVE Life Sciences股价,WAVE Life Sciences股市,WAVE Life Sciences股票价格,WAVE Life Sciences股票交易,WAVE Life Sciences股票购买,WAVE Life Sciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"WAVE Life Sciences(WVE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest WAVE Life Sciences(WVE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction